Genelux Corp. (GNLX)
2.56
+0.04
(+1.59%)
USD |
NASDAQ |
Oct 02, 16:00
2.56
0.00 (0.00%)
After-Hours: 20:00
Genelux Price to Book Value : 7.166 for Oct. 2, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 7.166 |
| October 01, 2026 | 7.054 |
| September 30, 2026 | 7.082 |
| September 29, 2026 | 6.858 |
| September 28, 2026 | 6.914 |
| September 25, 2026 | 6.942 |
| September 24, 2026 | 6.802 |
| September 23, 2026 | 7.040 |
| September 22, 2026 | 7.306 |
| September 21, 2026 | 7.166 |
| September 18, 2026 | 7.082 |
| September 17, 2026 | 7.082 |
| September 16, 2026 | 6.55 |
| September 15, 2026 | 6.914 |
| September 14, 2026 | 7.110 |
| September 11, 2026 | 6.970 |
| September 10, 2026 | 6.942 |
| September 09, 2026 | 7.054 |
| September 08, 2026 | 7.110 |
| September 04, 2026 | 6.83 |
| September 03, 2026 | 7.054 |
| September 02, 2026 | 7.138 |
| September 01, 2026 | 7.278 |
| August 31, 2026 | 7.320 |
| August 28, 2026 | 7.446 |
| Date | Value |
|---|---|
| August 27, 2026 | 8.062 |
| August 26, 2026 | 7.642 |
| August 25, 2026 | 7.614 |
| August 24, 2026 | 7.614 |
| August 21, 2026 | 7.614 |
| August 20, 2026 | 7.670 |
| August 19, 2026 | 7.502 |
| August 18, 2026 | 7.278 |
| August 17, 2026 | 7.558 |
| August 14, 2026 | 7.670 |
| August 13, 2026 | 7.362 |
| August 12, 2026 | 7.558 |
| August 11, 2026 | 7.418 |
| August 10, 2026 | 7.614 |
| August 07, 2026 | 7.446 |
| August 06, 2026 | 7.558 |
| August 05, 2026 | 7.026 |
| August 04, 2026 | 7.894 |
| August 03, 2026 | 8.342 |
| July 31, 2026 | 8.230 |
| July 30, 2026 | 8.538 |
| July 29, 2026 | 7.922 |
| July 28, 2026 | 8.174 |
| July 27, 2026 | 8.258 |
| July 24, 2026 | 8.090 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Arcutis Biotherapeutics, Inc. | 14.33 |
| ACADIA Pharmaceuticals, Inc. | 2.628 |
| Alnylam Pharmaceuticals, Inc. | 21.70 |
| Savara, Inc. | 6.877 |
| Vericel Corp. | 5.552 |
Price to Book Value Related Metrics
| PS Ratio | 13176.76 |
| PEG Ratio | -2.277 |
| Price | 2.56 |
| Earnings Yield | -33.90% |
| Market Cap | 115.46M |
| PEGY Ratio | -2.277 |